Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-12-021304)

Filing Details

Accession Number:: 0001209191-12-021304
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2012-04-03 13:00:00
Reporting Period:: 2012-04-03

Filing Date:: 2012-04-03
Accepted Time:: 2012-04-03 16:14:34
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1145404	Cornerstone Therapeutics Inc	CRTX	Pharmaceutical Preparations (2834)	043523569

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1363558	A Craig Collard	C/O Cornerstone Therapeutics Inc. 1255 Crescent Green Drive, Suite 250 Cary NC 27518	Chief Executive Officer	Yes	Yes	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2012-04-03	1,443,913	$6.25	0	No	4	S	Indirect	By Carolina Pharmaceuticals Ltd.

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	By Carolina Pharmaceuticals Ltd.

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	1,567,225	Indirect	By Cornerstone Biopharma Holdings, Ltd.

Footnotes

Shares sold to Chiesi Farmaceutici SpA at a price of $6.25 per share pursuant to a stock purchase agreement dated March 16, 2012.
The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that the reporting person is the beneficial owener of the securities for purposes of Section 16 or for any other purpose.